Changes in Plasma Concentrations of Hypoxanthine and Uric Acid Before and After Hemodialysis

Shahbazian, Heshmatollah; Moghadam, Ahmad Zand; Ehsanpour, Ali; Khazaali, Mahyar
July 2009
Iranian Journal of Kidney Diseases;Jul2009, Vol. 3 Issue 3, p151
Academic Journal
Introduction. Purine metabolites constitute a major class of uremic toxins, and reliable characterization of which helps nephrologists to choose the most appropriate treatment for the patients individually. In the present study, we assessed plasma concentrations of hypoxanthine and uric acid as purine metabolites in patients on maintenance hemodialysis, before and after a dialysis session. Materials and Methods. A total of 20 patients on maintenance hemodialysis were enrolled in this study. All of the patients underwent a routine 4-hour dialysis, as scheduled 3 times per week. Polysulfone membranes and bicarbonate dialysis solution were used in all dialysis sessions. Blood specimens were taken from the arteriovenous fistula immediately before and after one hemodialysis session, in order to measure plasma concentrations of hypoxanthine and uric acid by high-performance liquid chromatography, and to compare the predialysis and postdialysis values. Results. Before hemodialysis, the mean plasma hypoxanthine and uric acid concentrations were 18.93 ± 8.28 μmol/L and 44.16 ± 22.88 μmol/L, respectively. After hemodialysis, these concentrations reduced to 13.68 ± 4.42 μmol/L and 15.61 ± 11.12 μmol/L, respectively. Hypoxanthine concentration had a 27.7% decrease after hemodialysis (mean difference, 5.25 ± 6.24 μmol/L; 95% confidence interval, 2.32 to 8.10; P < .001). Also, uric acid concentration decreased by 64.6% (mean difference, 28.55 ± 14.39 μmol/L; 95% confidence interval, 21.81 to 32.28; P < .001). Conclusions. Plasma concentrations of hypoxanthine and uric acid are higher than normal before hemodialysis, and they decrease significantly after hemodialysis; however, both of them may be still higher than normal values.


Related Articles

  • HPLC and UPLC for Determining Drugs in Blood (A Review). Medvedev, Yu.; Ramenskaya, G.; Shokhin, I.; Yarushok, T. // Pharmaceutical Chemistry Journal;Jul2013, Vol. 47 Issue 4, p225 

    The application of HPLC and UPLC techniques to the analysis of drugs in blood plasma during bioequivalence investigations and clinical monitoring was reviewed. Various methods of sample preparation, chromatography, and detection were considered and their specific features were pointed out.

  • Moderator's view: A ‘secular’ view on vascular access in haemodialysis. Lameire, Norbert; Van Biesen, Wim // Nephrology Dialysis Transplantation;Oct2012, Vol. 27 Issue 10, p3758 

    No abstract available.

  • RP-HPLC Method for the Estimation of 6-Mercaptopurine in spiked human plasma and pharmaceutical formulations. Naik, Keerti M.; Nandibewoor, Sharanappa T. // Journal of Analytical Chemistry;Dec2013, Vol. 68 Issue 12, p1085 

    Abstarct: A simple, rapid and accurate reverse-phase high-performance liquid chromatography ( RP-HPLC) method for the determination of 6-mercaptopurine ( 6-MP) in pharmaceutical formulations and spiked human plasma samples has been developed and validated. The assay of the drug was performed on...

  • Surgical salvage of thrombosed arteriovenous fistulas and grafts by interventional nephrologists. Ponikvar, Rafael // HealthMed;2010 Supplement 1, Vol. 4, p221 

    Surgically skilled interventional nephrologists are capable to create not only typical radiocephaiic arteriovenous fistula but also all kinds of native arteriovenous fistulae and grafts as well as to perform surgical salvage procedures for thrombosed arteriovenous fistulas and grafts....

  • Clinical Relevance of Liquid Chromatography Tandem Mass Spectrometry as an Analytical Method in Microdose Clinical Studies. Yamane, Naoe; Tozuka, Zenzaburo; Kusama, Makiko; Maeda, Kazuya; Ikeda, Toshihiko; Sugiyama, Yuichi // Pharmaceutical Research;Aug2011, Vol. 28 Issue 8, p1963 

    Purpose: To investigate the potency of LC-MS/MS by means of sensitivity and the applicability for cassette dosing in microdose clinical trials. Methods: Thirty one top-selling 31 drugs were spiked to human plasma, extracted, and analyzed by LC-MS/MS. Results: The lower limits of quantification...

  • Randomized controlled trial of clopidogrel to prevent primary arteriovenous fistula failure in hemodialysis patients. Ghorbani, A.; Aalamshah, M.; Shahbazian, H.; Ehsanpour, A.; Aref, A. // Journal of Conservative Dentistry;Jan/Feb2009, Vol. 12 Issue 1, p57 

    The optimal vascular access for chronic maintenance hemodialysis is the arteriovenous fistula (AVF). Several studies suggest a role for antiplatelet agents in the prevention of primary AVF failure. A double-blind, randomized trial was conducted to assess the efficacy and safety of clopidogrel in...

  • Relationship between High-Performance Liquid Chromatography Fingerprints and Uric Acid-Lowering Activities of Cichorium intybus L. Chun-Sheng Zhu; Bing Zhang; Zhi-Jian Lin; Xue-Jie Wang; Yue Zhou; Xiao-Xia Sun; Ming-Liang Xiao // Molecules;May2015, Vol. 20 Issue 5, p9455 

    This study aimed to explore the spectrum-effect relationships between high-performance liquid chromatography fingerprints and the uric acid-lowering activities of chicory. Chemical fingerprints of chicory samples from ten different sources were determined by high-performance liquid...

  • Genistein alters caffeine exposure in healthy female volunteers. Chen, Yao; Xiao, Chang-Qiong; He, Yi-Jing; Chen, Bi-Lian; Wang, Guo; Zhou, Gan; Zhang, Wei; Tan, Zhi-Rong; Cao, Shan; Wang, Li-Ping; Zhou, Hong-Hao // European Journal of Clinical Pharmacology;Apr2011, Vol. 67 Issue 4, p347 

    Purpose: This study investigated the effect of 1 g genistein daily for 14 days on caffeine-based metrics of cytochrome P4501A2 (CYP1A2), cytochrome P4502A6 (CYP2A6), N-acetyltransferase 2 (NAT2), and xanthine oxidase (XO). Methods: A single dose of 100 mg caffeine was administered once before...

  • Effect of clarithromycin and fluconazole on the pharmacokinetics of montelukast in human volunteers. Hegazy, Sahar; Mabrouk, Mokhtar; Elsisi, Alaa; Mansour, Noha // European Journal of Clinical Pharmacology;Sep2012, Vol. 68 Issue 9, p1275 

    Objective: Montelukast, a leukotriene receptor antagonist, is used in the treatment of asthma. The objective of the study reported here was to determine whether multiple doses of clarithromycin or fluconazole affect the pharmacokinetics of montelukast. Methods: This was a four-phase cross-over...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics